Community Health Worker Program for Heart Failure
Trial Summary
What is the purpose of this trial?
This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health Inequities by Early PreVEntion in the GREAT LakEs Region) Center (IRB 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities and downstream Black-White lifespan inequality in two cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center will involve three separate but related projects that aim to mitigate health disparities in risk factor control for three chronic conditions, hypertension (HTN, Project 1), heart failure (HF, Project 2) and coronary heart disease (CHD, Project 3), which drive downstream lifespan inequality. All three projects will involve the use of Community Health Workers (CHWs) to deliver an evidence-based practice intervention program called PAL2. All three projects will also utilize the PAL2 Implementation Intervention (PAL2-II), which is a set of structured training and evaluation strategies designed to optimize CHW competence and adherence (i.e., fidelity) to the PAL2 intervention program. The present study is Project 2 of the ACHIEVE GREATER Center.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, it mentions that participants with certain conditions, like uncontrolled diabetes or severe blood pressure, are excluded, which might imply some medication adjustments could be necessary.
What data supports the effectiveness of the treatment PAL2, PAL2, PAL2 Implementation Intervention (PAL2-II), PHARM-PAL2 for heart failure?
Research shows that community health workers (CHWs) can improve care for heart failure patients by reducing hospital visits and enhancing access to care. CHWs have been effective in managing chronic diseases like hypertension, which is a risk factor for heart problems, suggesting they could also help with heart failure management.12345
Is the Community Health Worker Program for Heart Failure safe for humans?
How is the PAL2 treatment for heart failure different from other treatments?
The PAL2 treatment is unique because it involves community health workers (CHWs) who help bridge the gap between underserved communities and the healthcare system, improving access to care and patient outcomes. This approach is different from traditional treatments as it focuses on addressing social determinants of health and enhancing patient support and education.128910
Research Team
Eligibility Criteria
This trial is for self-identified Black/African American adults living in the Detroit area with high blood pressure or additional heart failure risk factors. It's not for those with uncontrolled diabetes, resistant hypertension, current pregnancy plans, previous heart failure diagnosis, multiple anti-diabetic drugs use, or extremely high blood pressure.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the Pharm-PAL2 intervention via Mobile Health Units to control hypertension and prevent heart failure
Durability Phase
Continued monitoring and support to maintain intervention effects
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- PAL2 (Behavioral Intervention)
- PHARM-PAL2 (N/A)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Henry Ford Health System
Lead Sponsor
Wayne State University
Collaborator
Amanda Bryant-Friedrich
Wayne State University
Chief Executive Officer since 2023
PhD in Pharmaceutical Sciences
Dr. Polsky
Wayne State University
Chief Medical Officer since 2023
MD from Wayne State University